Rheos Capital Partners

藤野英人 serves as the firm's representative and public-facing leader, though Rheos does not publish a dedicated CIO title or investment committee roster. The firm's website and regulatory disclosures identify him as the central figure overseeing the 'Hifumi' fund strategies. Day-to-day portfolio management responsibilities are not broken out individually.

Rheos operates primarily as a registered Japanese asset manager running public-equity funds, but its crossover strategy — most explicitly through the 'Hifumi Crossover Pro' vehicle — carves out an allocation to unlisted private companies. The firm's own description places it within the investment trust and advisory business, not a dedicated buyout or venture capital platform.

The firm's structure indicates direct investment in both listed and unlisted securities through its own vehicles, rather than committing as a limited partner to external funds. Its crossover fund holds direct stakes in private companies alongside a public-equity portfolio, and there is no public record of Rheos acting as an LP in third-party private equity or venture funds.

Rheos has not published a stage-specific mandate, but the crossover structure — combining liquid stocks with illiquid positions — suggests a bias toward later-stage or pre-IPO companies where valuation visibility and exit timelines are shorter than traditional venture. No specific portfolio company names have been disclosed.

Total AUM is undisclosed. The firm disclosed that its direct-sales channel alone surpassed ¥300 billion in March 2026. The crossover fund had exceeded ¥50 billion as of April 2026, representing only one strategy within a broader product lineup that includes multiple public-equity funds distributed through banks and brokerages.